General fungal cellular targets

General fungal cellular targets encompass a broad array of molecular structures and metabolic pathways essential for fungal growth and survival, which are exploited by antifungal drugs to achieve selective toxicity (PubMed, Creative Biolabs). These targets are typically unique to fungi or significantly different from human homologs, such as the fungal cell wall, which contains chitin and beta-glucans, and the cell membrane, which utilizes ergosterol instead of cholesterol (Homework.Study.com, Creative Biolabs). Key therapeutic targets include enzymes like lanosterol 14-alpha-demethylase, inhibited by azoles, and 1,3-beta-glucan synthase, the target of echinocandins (PubMed, ResearchGate). Other targets involve nucleic acid synthesis, targeted by flucytosine, and microtubule assembly, targeted by griseofulvin (ResearchGate, Creative Biolabs). Because this term refers to a collective group of distinct proteins and structural components rather than a single molecular entity, it serves as a high-level classification for antifungal mechanisms of action rather than a specific therapeutic target (PubMed).

Other names

Fungal targetsAntifungal targetsFungal molecular targetsCellular targets of antifungalsAntifungal drug targets

Antifungal agents target various essential fungal processes including ergosterol biosynthesis (inhibited by azoles and allylamines), cell membrane integrity (disrupted by polyenes), cell wall synthesis (inhibited by echinocandins), and nucleic acid synthesis (inhibited by flucytosine) (PubMed, ResearchGate).